With the previous year in the rearview and exciting developments already in the mix for 2024, Novo Nordisk’s CEO is taking home a cool 13% raise for his performance in 2023.
In total, Novo’s chief Lars Fruergaard Jørgensen pocketed 68.2 million Danish kroner (around $9.9 million) for the year—an increase over the 60.1 million DKK he took home for his work in 2022.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,